Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06080035 · ClinicalTrials.gov registry record · NA

The Effects of Cetyl Tranexamate Mesylate on the Appearance of Acne-Related Hyperpigmentation

A NA study of Acne and Hyperpigmentation, sponsored by Integrative Skin Science and Research.

Completed
Registry status
NA
Development phase
22
Enrollment target
1
Study location

NCT06080035 is a NA study of Acne and Hyperpigmentation that has completed, run by Integrative Skin Science and Research. The registered enrollment target is 22 participants, below the 142-participant average among 26 other Acne trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06080035, a NA study of Acne and Hyperpigmentation, has completed, sponsored by Integrative Skin Science and Research.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess the effects of Cetyl Tranexamate Mesylate on acne-related hyperpigmentation through a specific delivery form known as TeraCeutic TXVector.

Interventions

  • OTHER Topical Cetyl Tranexamate Mesylate

Study Locations (1)

California

  • Integrative Skin and Research - Sacramento

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2023-11-06
Est. Completion 2024-01-11
Phase NA

What the Registry Record Tells You About NCT06080035

The ClinicalTrials.gov registry entry for NCT06080035 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 142-participant average among 26 other Acne trials with a reported enrollment target (85% lower). The listed sponsor is Integrative Skin Science and Research, which has 15 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Acne appearing as the primary indexed condition, and to 1 intervention - of which Topical Cetyl Tranexamate Mesylate is the first listed.

NCT06080035 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06080035 about?

NCT06080035 is a clinical study titled "The Effects of Cetyl Tranexamate Mesylate on the Appearance of Acne-Related Hyperpigmentation". The purpose of this study is to assess the effects of Cetyl Tranexamate Mesylate on acne-related hyperpigmentation through a specific delivery form known as TeraCeutic TXVector.

What is the current status of trial NCT06080035?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2023-11-06. Estimated completion is 2024-01-11.

What conditions does trial NCT06080035 study?

This clinical trial studies the following conditions: Acne, Hyperpigmentation, Post-inflammatory Hyperpigmentation.

What interventions are being tested in trial NCT06080035?

The interventions under investigation include: Topical Cetyl Tranexamate Mesylate (OTHER).

Who is sponsoring clinical trial NCT06080035?

This trial is sponsored by Integrative Skin Science and Research, which has 15 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06080035 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acne

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.